James Evangelista - Profile and Investment Details

Investor Profile

James Evangelista is a Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Exonics Therapeutics, Remix Therapeutics, NGM BiopharmaceuticalsConstellation Pharmaceuticals, Peloton Therapeutics, Carmot Therapeutics, Kallyope, PTC Therapeutics, Seragon Pharmaceuticals, Immune Design, Sagimet Biosciences, Cyterix Pharmaceuticals, Hexagon Bio, Circle Pharma, Tenaya Therapeutics, Igenica, ORIC Pharmaceuticals, Casma Therapeutics, Surrozen, Accent Therapeutics, ProNeurotech, Escient Pharmaceuticals, A2 Biotherapeutics, Effector Therapeutics, Gritstone Oncology, Revolution Medicines, Neurona Therapeutics, Rapt Therapeutics, Arcus Biosciences, Plexium, Synthekine, Nurix Therapeutics, Ribon Therapeutics, Flexus Biosciences, Aragon Pharmaceuticals, . Over time, James Evangelista has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether James Evangelista is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Portfolio Management, Education, Finance, Biotechnology, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with James Evangelista, as their portfolio suggests a familiarity and interest in this area.

Understanding James Evangelista’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.